Related Experiment Video

Updated: Jun 17, 2026

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery
07:25

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery

Published on: August 18, 2023

[To explore a route to liver cancer research with Chinese features]

Zhao-you Tang

    Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
    |December 22, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
    07:59

    Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

    Published on: September 3, 2021

    Related Experiment Videos

    Last Updated: Jun 17, 2026

    Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery
    07:25

    Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery

    Published on: August 18, 2023

    Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
    07:59

    Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

    Published on: September 3, 2021

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...

    Articles linked to this work by shared authors, journal, and citation graph.

    Liver transplantation using an otherwise-wasted partial liver resection graft.

    Hepatobiliary & pancreatic diseases international : HBPD INT·2024

    A clinically feasible circulating tumor cell sorting system for monitoring the progression of advanced hepatocellular carcinoma.

    Journal of nanobiotechnology·2023

    Exosomal proteomics identifies RAB13 as a potential regulator of metastasis for HCC.

    Hepatology communications·2023

    Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma.

    Annals of surgical oncology·2022

    Physical activity improves outcomes of combined lenvatinib plus anti-PD-1 therapy in unresectable hepatocellular carcinoma: a retrospective study and mouse model.

    Experimental hematology & oncology·2022

    Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations.

    Liver cancer·2021

    [Expert Consensus on Clinical Application of Izalontamab Brengitecan (2026 Edition)].

    Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026

    [CACA guidelines for the prevention and control of nausea and vomiting induced by anticancer therapy (2026 edition)].

    Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026

    [Chinese clinical practice guidelines for standardized diagnosis and treatment of presacral cysts (2026 edition)].

    Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026

    [Efficacy comparisons of chemotherapy regimens with different intensities in high-risk pediatric hepatoblastoma].

    Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026

    [Efficacy and safety of different sizes drug eluting beads in the treatment of colorectal cancer liver metastasis by TACE].

    Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026

    [Dynamically monitoring circulating tumor DNA as a biomarker for immunotherapy in advanced esophageal squamous cell carcinoma].

    Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026

    CCT8 associates with the MYO10 motor domain and regulates filopodia and breast cancer cell invasion.

    Journal of cell science·2026

    Probiotic intervention in colorectal cancer: the cytotoxic and apoptotic potential of Lactobacillus cell-free supernatants.

    Turkish journal of biology = Turk biyoloji dergisi·2026

    Bisphenol A and ovarian cancer: emerging evidence and potential biological mechanisms.

    Frontiers in cell and developmental biology·2026

    Correction: Cell cycle dysregulation: a central hub in colitis-associated colorectal carcinogenesis.

    Frontiers in immunology·2026

    CircHMGA2 facilitates proliferation and invasion of laryngeal squamous cell carcinoma cells and M2 macrophage polarization via the miR-384/ROCK1 axis.

    Central-European journal of immunology·2026

    Mitochondrial transfer: a new perspective on tumor-microenvironment crosstalk driving metastasis.

    Frontiers in immunology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us